Perturbation-response genes reveal signaling footprints in cancer gene expression
暂无分享,去创建一个
Bertram Klinger | Nils Blüthgen | Julio Saez-Rodriguez | Michael Schubert | Mathew J. Garnett | J. Sáez-Rodríguez | M. Garnett | N. Blüthgen | Michael Schubert | B. Klinger | Martina Klünemann | Martina Klünemann
[1] B. Brüne,et al. PI3K/Akt Is Required for Heat Shock Proteins to Protect Hypoxia-inducible Factor 1α from pVHL-independent Degradation* , 2004, Journal of Biological Chemistry.
[2] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[3] Helen E. Parkinson,et al. ArrayExpress—a public database of microarray experiments and gene expression profiles , 2006, Nucleic Acids Res..
[4] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[5] T. Jacks,et al. Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome , 2004, Cell.
[6] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[7] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[8] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[9] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[10] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[11] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[12] Michal Sheffer,et al. Pathway-based personalized analysis of cancer , 2013, Proceedings of the National Academy of Sciences.
[13] V. Tabor,et al. Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis , 2013, Cancer Cell International.
[14] B. Neel,et al. TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway. , 2011, Genes & development.
[15] Cheryl H. Arrowsmith,et al. Prevalent p53 mutants co-opt chromatin pathways to drive cancer growth , 2015, Nature.
[16] F. Chibon,et al. Cancer gene expression signatures - the rise and fall? , 2013, European journal of cancer.
[17] Avi Ma'ayan,et al. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers , 2012, Bioinform..
[18] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[19] Jeffrey T. Chang,et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.
[20] Mariano J. Alvarez,et al. Network-based inference of protein activity helps functionalize the genetic landscape of cancer , 2016, Nature Genetics.
[21] Bertram Klinger,et al. Discovering causal signaling pathways through gene-expression patterns , 2010, Nucleic Acids Res..
[22] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[23] Jianmin Wu,et al. Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling , 2014, Cell.
[24] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[25] Rafael A. Irizarry,et al. A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..
[26] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] Gene Ontology Consortium. The Gene Ontology (GO) database and informatics resource , 2003 .
[28] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[29] Gary D Bader,et al. Pathway and network analysis of cancer genomes , 2015, Nature Methods.
[30] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[31] Michael L. Gatza,et al. A pathway-based classification of human breast cancer , 2010, Proceedings of the National Academy of Sciences.
[32] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[33] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[34] A. Levine,et al. Tumor-Associated Mutant p53 Drives the Warburg Effect , 2013, Nature Communications.
[35] Wei Zhao,et al. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. , 2009, Investigative ophthalmology & visual science.
[36] B Marshall,et al. Gene Ontology Consortium: The Gene Ontology (GO) database and informatics resource , 2004, Nucleic Acids Res..